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Abstract
Objectives: To investigate whether a near infrared spectro-
scopy (NIRS) system is useful for evaluation of the placental
function in cases of fetal growth restriction (FGR).
Methods: Subjects included 282 delivered neonates of
appropriate for gestational age (AGA) and 44 small for ges-
tational age (SGA) babies. The measurement of the concen-
tration of oxyhemoglobin (HbO2) and deoxyhemoglobin
(HHb) was conducted using transabdominal NIRS targeting
the placenta at around 20 weeks, 30 weeks and after
36 weeks of gestation and calculated tissue oxygen indexes
(TOIsHbO2/total Hb). We correlated between TOIs and
causes of FGR.
Results: TOIs measured immediately before delivery in the
SGA group with severe pre-eclampsia (79.2"3.8 (%"stan-
dard deviation (SD); Ps0.002)) and placental abnormalities
(78.2"3.6; Ps0.043) were higher than in the AGA group
(74.0"4.5). TOIs in the SGA group with umbilical cord
abnormalities were lower (69.7"7.7; Ps0.024) than in the
AGA group.
Conclusion: NIRS might provide information about blood
oxygen level of the intervillous space and thus explain the
cause of FGR.
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Although various factors effect fetal growth restriction
(FGR), its actual cause is rarely diagnosed prenatally.
Placental morphological abnormalities and some umbilical
cord abnormalities may be prenatally detected using ultra-
sonography. However, it is still difficult to evaluate placental
function and its relationship to FGR, though the morpholog-
ical alterations of the placenta can be evaluated retrospec-
tively by pathological examinations. Antenatally, only some
circulatory activity can be measured in the uterus but no
direct methods have yet been established to determine the
functional status of the placenta. If the placental oxygenation
conditions could be non-invasively measured during preg-
nancy, it would provide valuable information about oxygen-
ation of the fetus, association between growth restriction,
hypoxia, etc.
Near-infrared spectroscopy (NIRS), first described by Job-
sis in 1977 w2x, is a non-invasive and convenient method of
monitoring tissue oxygenation of a number of intact organs,
especially in neurology and cardiology. However, only a few
studies w3, 5x have applied NIRS for placental function.
The aim of this study was to investigate whether NIRS
via the maternal abdominal approach is useful for evaluation
of the placental function in FGR cases.
Materials and methods
A prospective cohort study was conducted at the Perinatal Center
of Showa University School of Medicine between June 2007 and
August 2008. A total of 326 pregnant Japanese women who planned
to deliver at that hospital and whose placenta was located on the
anterior wall or the fundus of the uterus were enrolled. Informed
consent was obtained from all participants.
Transabdominal NIRS was conducted with the Hamamatsu NIRO
120 system (Hamamatsu Photonics KK, Hamamatsu, Japan) at
around 20 weeks (18–22 weeks), 30 weeks (28–32 weeks) and after
36 weeks’ gestation. The components of the NIRO system were
described elsewhere w3x. Briefly, four pulsed laser diodes are used
as the source of NIR light. These diodes typically produce light at
wavelengths of 775, 825, 850, and 905 nm. NIR light is directed to
the tissue via optical fibers in the probe. The light emerging from
the tissue is returned to the instrument through another optical fiber
in the probe and is detected by a photomultiplier tube. Transmitted
light intensities are recorded. Based on these records, the changes
in the concentration of the chromophores oxyhemoglobin (HbO2)
and Hb were calculated and displayed on the front panel of the
instrument.
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Table 1 Demographics of pregnancies with AGA and SGA fetuses.
Groups AGA SGA P-value
Number of cases 282 44
Maternal age 32.4"4.4 31.4"4.4 ns
Body mass index 20.3"2.6 20.1"2.3 ns
Parity (median, range) 0, 0–7 0, 0–4 ns
Gestation of age at delivery (w) 38.8"1.6 36.2"3.6 -0.01
Neonatal birth weight (g) 3027"356 1986"647 -0.01
Apgar 5 min (median, range) 9, 1–10 8, 1–10 -0.01
Apgar 5 min (median, range) 10, 3–10 9, 2–10 -0.01
Umbilical artery pH 7.32"0.08 7.31"0.07 ns
Data indicated means"SDs. Statistical analyses were performed between AGA and SGA by Mann-Whitney U-test.
AGAsappropriate for gestational age, SGAssmall for gestational age, SDsstandard deviation.
Figure 1 TOI values at 20 weeks, 30 weeks and after 36 weeks
of gestation: TOI values were 76.6"4.2, 74.0"4.7, 72.7"4.8
(%"SD) at 20 weeks, 30 weeks and after 36 weeks of gestation,
respectively. Bars indicate the mean values of TOIs and SDs. Sta-
tistical analyses were performed using ANOVA and the Bonferroni
post-hoc test.
The NIRO-120 is based on the spatially-resolved spectroscopy
approach and provides relative concentration changes (expressed in
DmM) of HbO2, deoxyhemoglobin (HHb), and the derived total
hemoglobin content (tHbsHbO2qHHb), while HbO2 and HHb
concentration changes are calculated. Consequently, tissue oxygen
indexes (TOIs) were calculated (TOIsHbO2/tHb) w10x.
Transmitting and receiving transducers were placed on the mater-
nal abdomen just above the placenta with a 4-cm interval to obtain
signals for the calculation of TOI. Subjects whose distance meas-
ured by ultrasonography between skin and placenta was more than
3 cm, were not included in this study, because this fat may disturb
obtaining accurate signals.
After delivery, the neonates were categorized into small for ges-
tational age (SGA) or appropriate gestational age (AGA). SGA was
defined as birth weight less than the 10th percentile for gestational
age referred to standard values of Japanese neonates. The maternal
and fetal complications, prenatal ultrasound findings, and abnor-
malities of placental and umbilical cord were reviewed. Thereafter,
the cases of SGA were estimated and stratified by the potential
cause of growth restriction. The causes of growth restriction includ-
ed the followings: maternal complication (heart abnormality, bron-
chial asthma, diabetes), uterine abnormality (bicornuate uterus,
myoma), low body mass index (-18), major fetal anomaly (heart
abnormality, pyelectasis), smoking, umbilical cord abnormality (vel-
amentous cord insertion, hypercoiled cord), placental abnormality
(infarction, deformed placenta, lobed placenta) and severe pre-
eclampsia (blood pressure )160 mm Hg or proteinuria )2 g/day).
This study analyzed the relationship between gestational age at
the time of measurement and TOIs, and that between TOIs and
causes of FGR.
The data were entered into a computerized data analysis program
(StatView for Windows, SAS Institute, Inc, Cary, NC). Continuous
variables were compared using the Mann-Whitney U-test. The cor-
relations between TOIs and the SD of neonatal birth weight were
compared using Pearson’s correlation coefficient. Multiple compar-
isons were used by an analysis of variance and Bonferroni post-hoc
test. Statistical significance was defined as a P-value of -0.05.
Results
Among the total 326 cases, 44 (13.5%) were SGA. The dem-
ographics of all pregnancies are shown in Table 1. Although
there were no differences in maternal age, BMI, parity and
umbilical artery pH between the groups, significant differ-
ences were observed in neonatal birth weight, in gestational
age at delivery and in the Apgar score. The causes of growth
restriction were stratified by maternal factors (bicornate uter-
us or small body mass index), umbilical cord abnormalities
(hypercoiled cord or velamentous cord insertion), placenta
abnormalities (infarction, lobed placenta or deformed pla-
centa), pre-eclampsia (severe proteinuria and/or hyperten-
sion) and unexplained FGR.
TOI values (%"SD) in all cases were 76.6"4.2,
74.0"4.7, 72.7"4.8 at 20, 30 and after 36 weeks of ges-
tation, respectively (Figure 1). TOI values decreased with
gestational age, and the value were significantly lower at 30
and after 36 weeks than at 20 weeks of gestation (P-0.001).
No correlation was observed between the SD of the neo-
natal birth weight and the TOI measured immediately before
delivery; (Figure 2), and regardless of the causes of FGR.
The last values of TOIs before delivery were significantly
higher in the AGA groups with uterine abnormalities, in the
SGA groups with placental abnormalities and with pre-
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Figure 2 Correlation between the Z-score of neonatal birth weight
and the last value of TOI before delivery: No correlation was
observed between the Z-score of neonatal birth weight and last value
of TOI before delivery.
Table 3 Last TOI in AGA and SGA fetuses stratified by main causations of fetal growth restriction.
Factor Cases TOI"SD (%) P-value
AGA 282 74.0"4.5
SGA 44 74.0"5.8
Maternal complication 8 71.9"4.5 0.203c
Umbilical cord abnormality 6 69.7"7.7 0.024a,b
Placenta abnormalities 5 78.2"3.6 0.043b
Pre-eclampsia 7 79.2"3.8 0.003a,c
Unexplained factor 18 73.2"5.0 0.498
Multiple comparisons were performed by analysis of variance (Ps0.001) and Bonferroni post-hoc test. P-values were compared with TOIs
in total cases of appropriate for gestational age. a,b,cSignificant differences between two group.
AGAsappropriate for gestational age, SGAssmall for gestational age, TOIstissue oxygen index, SDsstandard deviation.
Table 2 Relation between various maternal and intrauterine factors and tissue oxygen index (n) in 326 cases.
Factor AGA SGA Total
No Yes No Yes No Yes
Maternal complication 73.9"4.5 (273) 75.0"4.8 (9) 74.0"5.4 (40) 73.9"10.1 (4) 73.9"4.7 (313) 74.7"6.2 (13)
Uterine abnormality 73.9"4.5 (274) 77.1"3.6* (8) 74.0"5.9 (42) 74.0"4.2 (2) 73.9"4.7 (316) 76.5"3.7 (10)
Low body mass index 73.8"4.5 (239) 74.5"4.8 (43) 74.4"5.5 (37) 71.5"7.6 (7) 74.3"4.6 (276) 73.2"5.0 (50)
Fetal anomaly 74.0"4.6 (278) 73.5"1.8 (4) 74.0"5.8 (44) – 74.0"4.8 (322) 73.5"1.7 (4)
Smoking 74.1"4.6 (259) 74.6"3.4 (23) 75.1"6.1 (44) – 74.1"4.8 (303) 74.6"3.4 (23)
Umbilical cord abnormality 73.9"4.6 (256) 75.2"4.3 (26) 73.9"5.0 (31) 74.1"7.6 (13) 73.9"4.6 (287) 74.8"5.5 (39)
Placental abnormality 74.0"4.5 (265) 73.6"5.2 (17) 72.8"5.4 (31) 76.9"5.8* (13) 74.0"4.7 (296) 75.1"5.6 (30)
Pre-eclampsia 74.0"4.5 (280) 78.0"9.0 (2) 73.2"5.6 (38) 79.4"4.1* (6) 73.9"4.6 (318) 79.1"5.1a (8)
Data include multiplicities of abnormalities and indicate means"SDs. Statistical analyses were performed between no and yes in each
section by Mann-Whitney U-test. aSignificant difference between no and yes in the section (P-0.05).
AGAsappropriate for gestational age, SGAssmall for gestational age, SDsstandard deviation.
eclampsia, and in all cases with pre-eclampsia compared to
cases without (Table 2).
The last values of TOIs before delivery stratified by
presumed main cause of SGA are shown in Table 3. TOIs
in the SGA group with maternal complications were not dif-
ferent from the AGA group. The TOIs in SGA fetuses with
severe pre-eclampsia and placental abnormalities were sig-
nificantly higher than in the AGA group (Ps0.002 and
0.043). TOIs in the SGA group with umbilical cord abnor-
malities were significantly lower than in the AGA group
(Ps0.024).
Discussion
The main sources of change in the returning light signal by
absorbing the specific wave length light were probably due
to hemoglobin in the intervillous space, because it accounts
for the majority of hemoglobin existing in the light pathway.
Therefore, TOI mainly reflects the oxygenation of the inter-
villous blood.
A disturbance of blood flow in the placenta directly influ-
ences fetal growth. Kawamura et al. w5x reported an evalu-
ation of the placental function using NIRS during pregnancy
of 15 growth restricted fetuses compared with 15 normal
pregnant women. TOI values of the FGR group were signif-
icantly higher than those of the controls (77.8"1.6 vs.
70.3"0.4). The authors maintained that oxygen exchange
from maternal to fetal blood in the intervillous space may be
impaired due to dysfunctional villi; as a result, there would
be an increase in oxygen concentration in the intervillous
spaces, thus yielding higher TOI values. Our results, how-
ever, have shown that TOIs in SGA vary according to the
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different causes. SGA due to pre-eclampsia and placental
abnormalities had high TOIs, whereas those with umbilical
cord abnormalities showed low TOIs. Then, when we com-
pared TOIs between AGA and all SGA cases, there was no
difference.
Kawamura et al. w5x suggested that high TOI values reflect
high concentrations of HbO2 in intervillous space due to
low maternal-fetal oxygen exchange through the villous
membrane. In the current study, TOIs were high in, but not
only cases with FGR due to severe pre-eclampsia, TOIs in
placental abnormalities without pre-eclampsia were also
higher than in controls. We suggest that the decrease of phys-
ical activity would most likely occur once the ability of the
system to maintain normal status by increasing oxygen
extraction and carrying capacity had been fully utilized. Per-
haps, such procedures would preserve fetal growth during
the initial decrease of oxygen supply. After this, the fetus
would finally become growth restricted and in this situation,
intravillous oxygen would be more than normal because less
oxygen transportation to the fetus is caused by various pla-
cental abnormalities. Kaufmann et al. w4x suggested that pre-
eclampsia is associated with generalized impairment of
trophoblast invasion. Prefumo et al. w7x also suggested the
poor development of the placenta in early stages of preg-
nancy may cause pre-eclampsia. Redman and Sargent w9x
discussed that poor placentation does not always cause overt
pre-eclampsia, but can be associated with a SGA fetuses.
These cases might have a similar pathophysiological back-
ground as pre-eclampsia.
Interestingly, in the present study, the TOIs were signifi-
cantly lower in the SGA cases due to umbilical cord abnor-
malities. There have been some reports on the patho-
physiology of FGR with umbilical cord abnormalities. In a
review by Benirschke w1x, an association of chorangiosis
with cord problems was noted. Ogino and Redline w6x pos-
tulated that the pathogenesis of chorangiosis was hyper-
capillarization related to an increased intramural pressure,
perhaps related to venous obstruction at the umbilical cord
or fetal cardiac level. These structural changes may promote
oxygen transport from maternal to fetal circulation, then
decrease TOI, which represent oxygen content in the intra-
villous space. Although no pathological examinations were
done in the present study, a previous report w8x suggests that
umbilical obstructive abnormalities cause the terminal villi
to exaggerate the perfusion of oxygen between capillaries
and the intervillous space. Consequently, oxygen might eas-
ily escape from the intervillous space due to villous compli-
cations, lowering the oxygenated hemoglobin in the
intervillous space. Though it is difficult to explain why fetal
growth is restricted in this circumstance, it is worth noting
that the TOI were significantly lower in the growth restricted
fetuses with umbilical cord abnormalities.
There are some limitations in measurement of oxygenation
in the intervillous space of the placenta using NIRS. First, it
is only available for cases with anterior placentas and with
thin subcutaneous fat because light from the NIRS can only
penetrate as far as 4–5 cm. Second, the effects of other fac-
tors in the light pathway, such as blood flow in the maternal
abdominal wall and uterine wall, uterine contractions and
intra-villous fetal blood flow, are unknown. Finally, the rang-
es of the TOIs were too narrow to identify the abnormal
cases. However, despite the present limited applications of
NIRS, it might be improved in the near future due to con-
tinuing advances in spectroscopy technology.
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